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ABSTRACT Tracking disease progression in vivo is essential for the development of
treatments against bacterial infection. Optical imaging has become a central tool for
in vivo tracking of bacterial population development and therapeutic response. For a
precise understanding of in vivo imaging results in terms of disease mechanisms de-
rived from detailed postmortem observations, however, a link between the two is
needed. Here, we develop a model that provides that link for the investigation
of Citrobacter rodentium infection, a mouse model for enteropathogenic Esche-
richia coli (EPEC). We connect in vivo disease progression of C57BL/6 mice in-
fected with bioluminescent bacteria, imaged using optical tomography and X-ray
computed tomography, to postmortem measurements of colonic immune cell in-
ﬁltration. We use the model to explore changes to both the host immune re-
sponse and the bacteria and to evaluate the response to antibiotic treatment.
The developed model serves as a novel tool for the identiﬁcation and develop-
ment of new therapeutic interventions.
KEYWORDS antibiotic therapy, bioluminescent bacteria, Citrobacter rodentium,
dynamic modeling, espO mutant, in vivo imaging
Enteropathogenic Escherichia coli (EPEC) is a major cause of infantile diarrhea andmortality in low-income countries (1). The disease progress of EPEC can be studied
in mice using the mouse-speciﬁc pathogen Citrobacter rodentium, which mimics the
human course of infection. Following oral inoculation, C. rodentium ﬁrst colonizes the
cecum before the pathogen disseminates to the distal colon. The pathogen uses type
3 secretion system (T3SS) effectors for colonization, evasion of host immune responses,
including inhibition of NF-B signaling and inﬂammatory caspases (2), and inhibition of
intrinsic and extrinsic apoptosis (3–5). The infection peaks between 7 and 9 days
postinfection (p.i.) and plateaus for a few days before being cleared by 18 to 21 days
postinfection. Clearance of C. rodentium is mediated by robust inﬂammation, which
includes recruitment of immune cells (including neutrophils as well as Th-22 and Th-17
CD4 T and B cells) (6), production of antimicrobial peptides (7, 8), and competition
from the microbiota (9–12).
Infection with C. rodentium has been studied extensively using postmortem analyses
(6). The recent development of bioluminescent bacteria that emit visible light (13–15)
has enabled studying disease progression also in vivo using optical imaging. Optical
imaging has been emerging as a versatile tool to study disease progression in small
animals in vivo (16). Using bioluminescent or ﬂuorescent markers, cells and substances
can be tracked across the whole body (17). More and more research groups are
acquiring this state-of-the-art technique in-house to complement the traditional post-
mortem techniques that provide information on disease parameters on a more detailed
Received 18 July 2016 Returned for
modiﬁcation 9 August 2016 Accepted 16
October 2016
Accepted manuscript posted online 7
November 2016
Citation Ale A, Crepin VF, Collins JW,
Constantinou N, Habibzay M, Babtie AC,
Frankel G, Stumpf MPH. 2017. Model of host-
pathogen interaction dynamics links in vivo
optical imaging and immune responses. Infect
Immun 85:e00606-16. https://doi.org/10.1128/
IAI.00606-16.
Editor Andreas J. Bäumler, University of
California, Davis
Copyright © 2016 Ale et al. This is an open-
access article distributed under the terms of
the Creative Commons Attribution 4.0
International license.
Address correspondence to Gad Frankel,
g.frankel@imperial.ac.uk, or Michael P. H.
Stumpf, m.stumpf@imperial.ac.uk.
BACTERIAL INFECTIONS
crossm
January 2017 Volume 85 Issue 1 e00606-16 iai.asm.org 1Infection and Immunity
 o
n
 January 25, 2017 by Im
perial College London
http://iai.asm
.org/
D
ow
nloaded from
 
level but only at distinct time points and locations. Using a system for combined
bioluminescence and X-ray computed tomography (CT) imaging, bacterial burden can
be quantiﬁed and localized with precision.
However, in order to enable the interpretation of in vivo images in terms of
postmortem-derived disease parameters, a model that links whole-body in vivo imag-
ing results to cellular and molecular data obtained postmortem, not all of which can be
visualized, is crucial.
A model of the underlying biological processes that give rise to the signals that are
measured with whole-body imaging can place processes occurring at the cellular or
molecular scale in the context of processes taking place over a much larger scale, in
different parts of the animal, or at different time points during the course of disease. In
other contexts, such as in the investigation of inﬂammatory bowel disease, detailed
models of host-pathogen interaction in the gut have been described (18, 19). In this
study, we develop a model of C. rodentium infection to create a direct link between
state-of-the-art in vivo whole-body imaging results and detailed biological knowledge
at the cellular scale. We show how the model can be used to analyze changes in host
immune response, to study mutations in the pathogen, and to analyze and simulate the
response to antibiotic treatment.
RESULTS
Dynamics of C. rodentium colonization, clearance, and recruitment of immune
cells. We ﬁrst establish the general dynamics of host-pathogen interaction during C.
rodentium infection. These results are used to determine the model, to link experimen-
tal postmortem data to results from in vivo imaging, and to simulate the contribution of
host immunity to bacterial clearance.
Following oral administration, C. rodentium colonizes the cecum and colon of mice
(Fig. 1A). Bacteria are continually shed into the feces, and the level of bacteria in the
stool correlates with the burden of attached bacteria in the colon (6). We measured the
bacterial levels in the stool for wild-type C57BL/6 mice over the course of infection (Fig.
1C); the peak of infection is at day 8 postinoculation, and the infection is cleared at
around day 21. Clearance of C. rodentium is achieved through a combination of innate
and adaptive defense mechanisms and competition by the microbiota. Neutrophils, B
cells, and T cells play a major role in the elimination of the pathogen (6). We measured
recruitment of immune cells to colonic samples obtained postmortem (Fig. 1B). Neu-
trophils start accumulating in the colon at the early stage infection, followed by B cells
at a later stage; CD4 T cells are detected from day 14 postinfection.
We modeled how a change in bacterial shedding depends on the host immune
response. We included neutrophils and antibody-producing B cells as elimination
factors, and we accounted for their dependence on the presence of CD4 T cells. We
relied on the following assumptions: elimination of bacteria by neutrophils is propor-
tional to the measured levels of neutrophils, and B cells ﬁrst need to be activated before
they are effective; B cells are activated by CD4 T cells; and elimination through the
antibody response mediated by B cells is proportional to the levels of active B cells. We
further assume that the T cell population only effectively activates B cells after day 8.
Under these assumptions, we model the change in bacterial levels, C, in the colon
over time (dC/dt) by the simple equation dC/dt   · C   · N · C   · B · CD4 T ·
C   · C. The positive growth term ( · C) results in an increase in the bacterial load
over time, and the negative elimination terms (neutrophils [ · N · C] and B cells [ · B ·
CD4 T · C]) and the negative treatment term ( · C) result in decreases of the bacterial
load over time. The growth parameter, , represents the bacterial replication rate per
day, and the parameters  and  represent bacterial elimination rates per day per active
immune cell population. N is the concentration of neutrophils, B is the concentration of
B cells, and CD4 T is the concentration of CD4 T cells. The last term in the model
corresponds to elimination as a result of treatment. Initially we set the treatment
parameter, , to zero, but we will use this term later. We modeled the initial value of the
level of bacteria in the stool by C0  fCO, where CO is the concentration of bacteria
Ale et al. Infection and Immunity
January 2017 Volume 85 Issue 1 e00606-16 iai.asm.org 2
 o
n
 January 25, 2017 by Im
perial College London
http://iai.asm
.org/
D
ow
nloaded from
 
during oral gavage and the parameter f represents the fraction that is present in the
colon at day 2 of the infection.
The in vivo dynamics of this system have not previously been modeled, and
therefore we lack reliable estimates of model parameters (such as rates of killing of
bacteria due to different parts of the immune system). We therefore used the data
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FIG 1 Dynamics of wild-type C. rodentium infection. (A) Model schematic. After oral gavage, C. rodentium colonizes the cecum and colonic mucosa
and is shed in the stool. C. rodentium infection is cleared mainly by neutrophils and B cells activated by CD4 T cells. (B) Immune cell data from
colon samples. Neutrophils are shown as a percentage of live myeloid cells (plmc), and B cells and CD4 T cells are depicted as percentages of
live lymphocytes (pll). (C) Fit of the model to the wild-type data. Experimental data (squares), mean model estimate (line), and 90% conﬁdence
interval were calculated with the model (shaded area). (D) Model parameter estimates. The histograms show which values were accepted for each
of the parameters (marginal posterior parameter density). Higher counts indicate we found more good ﬁts with parameter combinations that
include those parameter values. The scatter plots show the correlation between two of the estimated parameters (pairwise posterior parameter
density). Dark blue areas indicate regions with a large number of accepted parameter combinations. The scatter plot of neutrophil parameters
against B cell parameters shows that combinations of small values for the neutrophil elimination rate and large values for the B cell elimination
rate and vice versa resulted in good ﬁts of the model to the data (negative correlation). The scatter plot of neutrophil parameters against growth
parameters shows that combinations of small values for the neutrophil elimination rate and small values of the growth rate, as well as larger
values for the neutrophil elimination rate and larger values of the growth rate, resulted in good ﬁts of the model to the data (positive correlation).
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generated here to obtain estimates of the parameters. We used a method that results
in not just one point estimate of the parameters, which would only correspond to one
good ﬁt of the model to the data, but instead generates multiple probable parameter
estimates that all result in good model ﬁts. This provides an estimate of the uncertainty
in the parameters, which may be due to biological variability or noise in the data (i.e.,
we infer parameters in a Bayesian setting) (20). We obtain estimates for the parameters
by ﬁtting the model to measurements of the bacterial load in the stool, obtained from
wild-type C57/BL6 mice infected with wild-type C. rodentium, assuming a direct corre-
lation between the levels of attached bacteria in the colon and bacteria in the stool (Fig.
1C and D). We used stool data to calibrate the model instead of imaging data, as stool
data are more abundantly available. In the next section we will link the model to in vivo
imaging data of the bacterial load in the abdomen.
We used the measured immune cell inﬁltration in the model as the input (N, B, and
CD4 T cells). We estimated the immune cell inﬁltration for time points between
measured time points using linear interpolation. To estimate parameters, we used an
algorithm (the Bayesian inference algorithm Metropolis-Hastings) which allowed us to
obtain multiple probable estimates for parameter values (we generated samples from
the posterior parameter distribution). This is a sequential method that starts with some
initial parameter estimates (sampled from prior parameter distributions that are de-
ﬁned according to our current knowledge about the parameter values) and iteratively
updates these estimates based on how well model simulations using the sampled
parameter values ﬁt the data (21, 22). Whether the estimate of the bacterial load is close
to the measured CFU per gram was determined by comparing it to the measured
variance in the bacterial levels at each time point (i.e., a Gaussian likelihood). We used
this set of parameter estimates to simulate trajectories of bacterial concentrations.
Figure 1C shows the mean and the interval that includes 90% of the modeled bacterial
loads (i.e., the 90% conﬁdence interval) calculated from these simulated trajectories,
which closely matched the measured trajectory of bacterial load.
The model allows us to measure the relative impact of the immune cell populations.
In particular, the negative correlation between  and  shows that a decrease in the
rate of elimination by neutrophils is compensated for by an increase in the rate of
elimination by B cells. Furthermore, we ﬁnd that the rate of elimination by neutrophils
increases when the bacterial growth rate is higher (positive correlation between  and
) (Fig. 1D).
In vivo bioluminescence imaging data. We linked the model results to longitudi-
nal whole-body C. rodentium imaging in vivo. We measured disease progression in four
mice infected with bioluminescent C. rodentium using the IVIS system for optical
tomography and X-ray CT from day 1 to the peak of infection at day 8. Reconstruction
of the three-dimensional (3D) bioluminescence distribution for a representative mouse
clearly shows a local increase in bioluminescence signal in the abdomen (Fig. 2B). We
quantify the bacterial load by summing the total bioluminescence signal in the
abdomen for each mouse at each time point (Fig. 2A). For the purpose of comparison
with model results, we normalized these signals to the one obtained at day 8. We
determined the trend in the means and standard deviations of the quantiﬁed imaging
data using a method that assumes a certain smoothness over time and for which no
additional parameters are necessary (we use Gaussian process [GP] regression, a
nonparametric Bayesian method for nonlinear regression [23, 24]). The trends apparent
in the quantiﬁed in vivo imaging data correspond nicely to the conﬁdence interval
calculated with the dynamic model (Fig. 2A).
Using the model, we predicted the outcome of imaging experiments. In Fig. 2C we
show the estimated mean bacterial loads on three different days. In this way, the model
can serve as a tool for experimental design (25, 26) and to monitor imaging outcomes
against predictions during the course of an ongoing experiment.
For the same four mice, we also acquired the 2D bioluminescence distribution at day
8 and the ex vivo 2D bioluminescence distribution of the mouse intestines (Fig. 2D). We
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quantiﬁed the signal in these images in the same way as that described above and
compared quantiﬁcation across the three acquisition methods (Fig. 2D and E). The
quantiﬁed signals correspond to the predicted conﬁdence interval.
Perturbations in the host immune response. Changes in the host immune cell
response, as observed, for example, when using knockout mice, can result in a change
in bacterial death rate due to altered immune system activity. We investigated the
effects different cells of the immune system have by the model parameters correspond-
ing to the activity of neutrophils () and B cells (), dissecting the contributions of these
different immune cell populations (Fig. 3). We either increased parameters by 50%,
decreased them by 50%, or set them to zero, and we compared the resulting model
simulations.
A change in the neutrophil term (Fig. 3, top row) has an impact on the height of the
peak of infection: even a small decrease in neutrophil effectiveness may lead to inability
to clear the infection. A change in the B cell term (Fig. 3, bottom row), being active
during the later stage of disease progression, has a less pronounced effect. Setting
activity of either cell type to zero would lead to inability to clear the infection.
The perturbations considered here can be related to knockout mice described in the
literature. A decrease in the accumulation of neutrophils and macrophages to the site
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of infection has been observed in MyD88/ mutant mice. These mice lack MyD88,
which is part of the signaling pathway of Toll-like receptors that activates inﬂammatory
cytokine production, and as a result the recruitment of neutrophils and macrophages
to the site of infection is impaired (27). Bacterial levels quickly expanded followed by
death from day 7 when the level of colonizing bacteria reached high levels. A similar
quick expansion toward high levels of bacterial burden is also observed in the corre-
sponding simulation (Fig. 3, top right image).
Setting both B cells and the T cell population to zero (Fig. 3, bottom right image) is
related to rag1-deﬁcient mutant mice. Infection in this mouse model experimentally
becomes a chronic infection (28). The corresponding simulation shows a similar pattern
of chronic infection, i.e., the immune response does not clear the infection over the
time scales considered here (or in the experiments).
Immune response to infection with C. rodentium espO deletion mutant.We next
used the model to investigate changes in the immune response when wild-type
C57BL/6 mice are infected with C. rodentium carrying a deletion of the T3SS effector
EspO, a homologue of OspE from Shigella, shown to stabilize focal adhesion and block
cell detachment (29, 30) (Fig. 4A).
We measured the levels of neutrophils, B cells, and CD4 T cells in colonic tissue
samples at four time points, as well as the level of bacterial shedding in the stool at 14
time points, spanning the course of infection. For the espO mutant, we observed a
signiﬁcantly higher bacterial load at days 14, 15, and 16 postinfection compared to
infection with wild-type C. rodentium. The recruitment of immune cells to the colon
following infection with the mutant was generally similar to what we observed during
wild-type infection (Fig. 4B), with the main difference being that T cell inﬁltration was
reduced on day 14.
We then further analyzed the dynamics by ﬁtting our model against C. rodentium
ΔespO stool measurements to characterize the response dynamics in this mutant
(estimating parameter values in the same way as was described above), using the
immune cell populations measured for the mutant as the starting point for the analysis
(Fig. 4B). We found that the estimated parameter correlations are similar to the
parameters we obtained when ﬁtting the wild-type infection dynamics, and that the
order of magnitude of the estimated parameters was the same (Fig. 4C and D).
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Elimination due to the B cell term in the model depends on B cell abundance, their
activation by CD4 T cells, and the estimated rate parameter. At day 14, the total
elimination rate corresponding to the active B cell term in the model was smaller during
infection with the ΔespO mutant than with the wild type, mainly due to the difference
in T cell abundance. This provides a possible explanation for the prolonged high
bacterial load during infection with the ΔespO mutant.
In order to validate this ﬁnding, we proceeded to measure the level of antibodies
against EspA experimentally following wild-type and ΔespO mutant infections (Fig. 4E),
and we found a signiﬁcantly lower level of C. rodentium-speciﬁc antibodies at day 14
during infection with the ΔespO mutant, conﬁrming the model prediction.
Therapeutic response. Finally, probing a pivotal aspect of bacterial infection
biology, we used the calibrated model to investigate the therapeutic response to two
antibiotic treatments. We evaluated antibiotic treatment of C. rodentium infection with
the bactericidal antibiotic ciproﬂoxacin and with bacteriostatic chloramphenicol. We
measured the C. rodentium bacterial burden in vivo during antibiotic chemotherapy
using 2D bioluminescence imaging between days 6 and 14 postinfection (Fig. 5A).
Treatment was started on day 6 postinfection and continued until the end of the
experiment. We quantiﬁed the imaging data by summing the signal (total ﬂux) from the
abdomen for each mouse (Fig. 5B), corrected for a constant background signal level of
1e5 photons/s, determined by quantifying the uninfected mouse images. The mea-
sured bacterial loads showed a sharp decrease when treatment with either antibiotic
was started, while the standard deviation was larger during treatment with chloram-
phenicol, suggesting more variable therapeutic effectiveness. The quantiﬁed 2D imag-
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ing data of wild-type infected mice show excellent correspondence to the calibrated
model (Fig. 5C, ﬁrst image).
We simulated treatment with ciproﬂoxacin by including the treatment term in the
model (), resulting in a steep decrease of the bacterial load, with a narrow conﬁdence
interval (Fig. 5C, second image). We modeled treatment with chloramphenicol by
changing the growth term in the model (). The bacterial growth rate is a net rate of
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bacterial multiplication and death, and stopping multiplication would make this term
negative. This results in a decrease in the bacterial load, but the progression is now
more variable than it would be if the treatment resulted in the direct killing of bacteria
(Fig. 5C, third image).
Finally, we can use the model for experimental design (25, 26) to determine the
effect of treatment during a speciﬁc time window. We can evaluate any combination of
starting and stopping times for the treatment by simulating with the model in order to
identify which would be the most relevant experiments to carry out. We simulated
treatment with a single dose of chloramphenicol and ciproﬂoxacin (at day 6) and found
that compared to treatment with a single dose of chloramphenicol, treatment with a
single dose of ciproﬂoxacin would have a larger beneﬁcial effect (Fig. 5D).
DISCUSSION
In this study, we developed a mechanistic modeling approach that links bacterial
colonization levels measured in vivo to the immune response, including possible
treatments. Whole-body bacterial colonization was measured in the stool and observed
in vivo, and immune cell populations (neutrophils, CD4 T cells, and B cells) in the
gastrointestinal tract were obtained postmortem. The modeled colonization levels
correspond very well to the colonization levels observed with both 2D- and 3D-
quantiﬁed in vivo imaging data. We used the mechanistic model to unravel the effect
of each cell type, as well as different antibiotic treatments, on the course of disease.
By simulating the outcomes corresponding to observed changes in host immune
response due to mutations described in the literature using our dynamic model, we
analyzed a range of separate literature studies within a single modeling framework.
The model allows us to draw conclusions regarding the role of each of the aspects of
the immune response in infection clearance in wild-type (C57BL/6) mice. Moreover, the
results obtained from wild-type mice suggest that the sometimes disparate behavior
found in different experimental studies can be combined into a clear picture of
infection dynamics with the help of the general model presented.
Second, we have analyzed the immune response to the C. rodentium ΔespO mutant
and found prolonged colonization compared to the wild type. Using the model, we
then predicted that a lower total elimination rate of B cells at day 14 could explain the
prolonged infection, which we validated experimentally by measurement of IgG anti-
bodies against EspA. This shows how to use the model to identify gaps in our
knowledge that require further investigation. Such successful predictions also serve to
validate the model. The success of the current study opens the prospect of using a
similar approach to analyze the inﬂuence of other effectors on the immune response,
such as Tir, which can affect the recruitment of neutrophils (31).
Finally, we have used the dynamic model to evaluate the response to antibiotics,
showing that simulations with the model accurately describe two different effects: the
effect of antibiotics that directly kill bacteria and the effect of antibiotics that stop
growth. Comparison with experiments shows that the model captures the variation of
colonization levels in time both qualitatively and quantitatively. Therefore, these types
of simulations can be used as a tool for experimental design and to compare imaging
results with expectations during imaging experiments. The simulations also allow
feasibility studies prior to experiments to indicate whether the experiments would
result in a detectable change in the bacterial load in vivo, for example, in the context
of probiotic experiments (32), and to explore different treatment regimens in terms of
timing and duration.
What is already becoming clear from the current study is that the use of bacterio-
static antibiotics risks that there remains for a considerable time, probably longer than
a typical or practical therapeutic time course, a pool of bacteria that are ready to lead
up to recurrent disease, persistence, and the evolution of antibiotic resistance. Here,
modeling of the type developed in the current study offers a rational way to prioritize
therapeutic approaches.
The modeling approach that we provide in this study can be applied to a wide range
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of experimental studies. In this work we have used quantiﬁed bioluminescence data,
but the same type of model can be used in combination with other state-of-the-art
optical imaging modalities, such as ﬂuorescence optical tomography and X-ray CT (33).
The emerging range of markers that is being developed for visualizing many different
disease parameters in vivo strongly increases the number of links that can be made
between in vivo and postmortem observations. Of particular interest are markers that
visualize the species included in the model in vivo, such as markers for neutrophils and
T cells.
Previous studies have also combined in vivo imaging and postmortem experiments
to analyze C. rodentium infection. For example, Hall et al. (15) have studied the role of
natural killer cells during C. rodentium infection using in vivo optical imaging, and
Cronin et al. (34) have studied the use of C. rodentium as a vehicle for cancer treatment.
The modeling approach that we describe here is ideally suitable to relate the reported
in vivo colonization levels to the postmortem-derived parameters in these studies to
provide a direct connection. Compared to available simulation platforms (19), the
limited number of host-pathogen interactions included in our model makes it speciﬁc
to the experimental setup, enabling us to directly validate theoretical results against
experiments. More detailed spatial information can be included using a model with
multiple compartments, and different scale levels can be included by combining this
with agent-based modeling, as has been done for investigating tuberculosis (35).
However, the spatial distribution of bacteria would be required, for example, by
visualizing this in vivo using X-ray CT contrast agents.
The relatively simple modeling approach that we employ, using an ordinary differ-
ential equation (ODE) model in combination with Bayesian parameter inference, facil-
itates the interaction between theory and experiment and enables combined research
toward the discovery of major biological breakthroughs. In this way, the developed
modeling framework serves as an interface between theory and experiment and can
play an important role in the future for speciﬁcally identifying gaps in our current
knowledge, to deﬁne key points that require further investigation, both in terms of
modeling and experiment, as well as for the development of suitable treatments.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and primers used in this study are
listed in Table 1. Bacteria were grown in Luria-Bertani (LB) medium supplemented with kanamycin (50
mg ml1) and nalidixic acid (50 mg ml1) as required.
C. rodentium espO deletion mutant strain ICC1333 was constructed using the PCR one-step  Red
recombinase method (37). Brieﬂy, the mutation was obtained using a PCR product containing the
TABLE 1 Strains and primers used in this study
Strain, plasmid, or
primer Description/nucleotide sequence (5= to 3=)
Reference or
source
Strains
ICC169 Wild-type C. rodentium O152 serotype 36
ICC180 Bioluminescent C. rodentium O152 serotype 36
ICC1333 C. rodentium espO deletion mutant, KanR This study
Plasmids
pKD46 Coding for the lambda Red recombinase 37
pKD4 Coding for the kanamycin resistance cassette 37
pICC929 pET28a expressing C. rodentium EspA with a C-terminal 6-histidine tag This study
Primers
EspO(W77A)-Fw GCCTCAGAAGCTCAGGCGATGTGCAAAATTATAG
EspO(W77A)-Rv CTATAATTTTGCACATCGCCTGAGCTTCTGAGGC
k1-EspO-del-Fw GCCGGATAACGGTGTACGCTGTATGTAATACAACCAGGAGGAAATCGATGCTGTGTAGGCTGGAGCTGCTTCG
k2-EspO-del-Rv GCAGACATCGGCACAATCCCTGTGGCGGTATCTGCCCGAAAAATCGTCAGGACATATGAATATCCTCCTTAGTTCC
Ext-EspO-check-Fw TGTATTGCATTAACAGGATCAC
Ext-EspO-check-Rv AGCTTTATGTATGTGTGCCTG
EspA-CR-NcoI-Fw CATGCCATGGATACATCAACTATGACATCAGTTGC
EspA-CR-EcoRI-Rv CGGAATTCGGTTTGCCAATGGGTATTGCTGAAACAG
Ale et al. Infection and Immunity
January 2017 Volume 85 Issue 1 e00606-16 iai.asm.org 10
 o
n
 January 25, 2017 by Im
perial College London
http://iai.asm
.org/
D
ow
nloaded from
 
kanamycin resistance gene ﬂanked by the 50 bases from the 5= and 3= ends of the targeted espO gene.
Plasmid pKD4 was used as the PCR template with primers k1-EspO-del-Fw and k2-EspO-del-Rv (Table 1).
The PCR product was electroporated into the recipient strain (wild-type C. rodentium [ICC169]) (Table 1)
carrying the Red system expression plasmid pKD46, and mutants were selected on LB plates with
kanamycin. Recombinant clones were cured of pKD46 plasmid by growth at the nonpermissive temper-
ature (42°C) and mutation conﬁrmed by PCR and DNA sequencing.
Animals. All animal experiments were performed in accordance with the Animals Scientiﬁc Proce-
dures Act of 1986 and were approved by the local Ethical Review Committee. Pathogen-free female 18-
to 20-g C57BL/6 mice were housed in HEPA-ﬁltered cages with sterile bedding, food, and water.
Mice inoculated with the wild-type strain and/or with phosphate-buffered saline (PBS) (mock
infection) were included in parallel with the mutant strain. A minimum of 5 and a maximum of 8 mice
per group was used for each experiment. Each experiment was repeated a minimum of two times.
Oral gavage of mice. Mice were inoculated by oral gavage with 200 l of overnight LB-grown C.
rodentium suspension in PBS (5  109 CFU) or mock infected with PBS. The number of viable bacteria
used as the inoculum was determined by retrospective plating onto LB agar containing antibiotics. Stool
samples were recovered aseptically at regular intervals after inoculation, and the number of viable
bacteria per gram of stool was determined by plating onto LB agar. At appropriate time points, mice
were culled and the colonic tissues collected for ﬂow cytometry analysis. Cardiac punctures were
performed for serum analysis.
For studies where mice were treated with antibiotics, at day 6 postinfection (p.i.) mice were gavaged
without anesthesia and with 200 l ciproﬂoxacin (100 mg/kg of body weight/day), chloramphenicol 100
mg/kg/day), or sterile distilled water (vehicle control) daily for 7 days.
Sample collection for ﬂow cytometry. A 4-cm segment of the terminal colon was cut, opened
longitudinally, and rinsed in sterile PBS. The tissue samples were placed in 4 ml of RPMI 1640
supplemented with 10% fetal bovine serum (FBS), penicillin-streptomycin (P/S), GlutaMAX, DNase
(10104159001; Roche), and liberase (540112001; Roche) in a C-Mac tube (Miltenyi Biotec), followed by
tissue dissociation using a gentleMACS dissociator (Miltenyi Biotec). First, the tissue was homogenized
using the intestine setting followed by incubation at 37°C and 5% CO2 for 30 min in a shaking incubator,
and then a ﬁnal dissociation step was performed using the lung 2 setting on the gentleMACS dissociator.
The digested preparation was disrupted to a single-cell suspension by passage through a 70-m sieve
(no. 352350; BD Labware/Falcon, USA) and resuspended in RPMI 1640 supplemented with 10% FBS and
P/S at 0.5  106 to 1  106 cells/ml.
Extracellular antigen analysis. Cells were stained for surface markers (such as CD4 CD8 T cells,
B220 CD3 B cells, and CD11b Ly6G neutrophils) in PBS containing 1% bovine serum albumin with
0.5% sodium azide (PBA) for 30 min at 4°C and ﬁxed with IC ﬁxation buffer (eBioscience) as described
previously (31). Nonviable cells were excluded using a ﬁxable near-infrared dead cell staining kit with
excitation at 633 or 635 nm (L10119; Invitrogen). Antibodies were purchased from BD Pharmingen or
eBioscience.
Data acquired on a BD Fortessa III with 20,000 live lymphocytes or myeloid events were analyzed with
the FlowJo (TreeStar) analysis program. Data are shown as a percentage of live myeloid or lymphocyte
gates. Myeloid and lymphocyte gates are determined by their position on the live/dead versus forward
scatter plots generated by the cytometer. A ﬂuorescence-minus-one (FMO) control was included for each
ﬂuorescent marker, and the expression of a particular marker was calculated by subtracting FMO
ﬂuorescence values from ﬂuorescent antibody levels.
Puriﬁcation of recombinant C. rodentium EspA. A pET28a-CR-EspA construct (pICC929) (Table 1),
expressing C. rodentium EspA with a carboxyl-terminal 6-His afﬁnity tag, was generated by PCR ampli-
ﬁcation from C. rodentium genomic DNA using primers EspA-CR-NcoI-Fw and EspA-CR-EcoRI-Rv (Table
1) and ligation of the NcoI- and EcoRI-digested amplicon into pET28a digested with the same
enzymes. The resulting pICC929 plasmid was transformed into E. coli K-12 strain BL21(DE3) Star cells,
which lack RNase E, to stabilize mRNA (Novagen), and the protein was expressed under isopropyl-
-D-thiogalactopyranoside (IPTG) induction and afﬁnity puriﬁed with nickel resin using standard pro-
tocols. The yield, size, stability, and purity of the expressed protein was assessed by SDS-PAGE. Protein
concentration was determined by the bicinchoninic acid method (Pierce Biotechnology, Inc., Rockford, IL,
USA) (38).
Detection of C. rodentium anti-EspA IgG in serum. An enzyme-linked immunosorbent assay
(ELISA) was used to detect serum IgG and antibodies to C. rodentium EspA. Sample dilutions were added
to the antigen-coated wells (0.5 to 1 mg of C. rodentium EspA per well) of a microtiter 96-well plate. After
incubation for 1 h at room temperature and subsequent washing, wells were incubated with horseradish
peroxidase-conjugated donkey anti-mouse IgG. After further washing, tetramethylbenzidine substrate
(TMB; Sigma) was added. Color formation was stopped after 10 min with 2.5 N sulfuric acid. The optical
density was measured at 450 nm (OD450) with background correction at 620 nm. Fold change was
calculated as the ratio to EspA IgG level detected in PBS mock-infected mice.
In vivo optical imaging of C. rodentium-infected mice. Whole-animal bioluminescence imaging
(BLI) was performed daily following infection using an IVIS SpectrumCT (PerkinElmer) (39). In some
studies, representative mice from each group were imaged using diffuse light imaging tomography with
integrated CT imaging (DLIT-CT) as previously described (6, 39). At necropsy on either day 8 or 14 p.i.,
whole organs or washed excised gastrointestinal tissues with the mucosa exteriorized were imaged.
Regions of interest were identiﬁed, and the total photon ﬂux was quantiﬁed (photons/s) using Living
Image software 4.3.1, service package 1 (PerkinElmer).
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Parameter inference. For estimation of the parameters in our model (the bacterial growth rate, ,
neutrophil and B cell elimination rates,  and , and the factor for initial bacterial load, f), we
implemented a probabilistic method called the Metropolis-Hastings algorithm, a Bayesian inference
scheme. This is a Markov chain Monte Carlo method that enables sampling from the joint posterior
distribution (21, 22); we used a Gaussian transition kernel to generate parameter proposals, normal priors
for the growth rate and immune cell parameters, and a lognormal prior for the initial value.
We assumed additive Gaussian noise and used the measured variance in bacterial levels in the stool
at each time point when calculating the likelihood. We linearly interpolated the immune cell populations
at time points between measurements. We initialized the growth and immune cell parameters (, , and
) at a value of 1 with prior bounds (1e3 and 1e3), and the initial value (f) at 1e4 with prior bounds
(1e9 and 1). We performed 10 million iterations, removed a burn-in of 250,000 iterations, and thinned
to every 5,000th iteration to give 1,950 sampled points from the posterior distribution. The posterior
parameter distributions, means, and conﬁdence intervals were calculated from the accepted parameter
population.
GP regression. We use Gaussian process (GP) regression (23, 40), a nonparametric Bayesian method
for nonlinear regression, to model the level of bacteria as a function of time using the experimental data.
We used Matlab functions from the Gaussian Process Regression and Classiﬁcation Toolbox, version 3.6
(23, 40), to infer values for the GP hyperparameters and ﬁt the GP regression models; we assumed a
zero-mean function and a squared covariance function and assumed the data are subject to normally
distributed noise with constant variance.
Statistics. GraphPad Prism software was used for all statistical calculations. The Mann-Whitney test
was used with PBS controls (or as indicated in the ﬁgure). P values of 0.05 were considered signiﬁcant
(*, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001).
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